Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/30375
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Karakaş, Didem | - |
dc.contributor.author | Ulukaya, Engin | - |
dc.date.accessioned | 2023-01-11T06:02:21Z | - |
dc.date.available | 2023-01-11T06:02:21Z | - |
dc.date.issued | 2017 | - |
dc.identifier.citation | Karakaş, D. vd. (2017). ''The MTT viability assay yields strikingly false-positive viabilities although the cells are killed by some plant extracts''. Turkish Journal of Biology, 41(6), 919-925. | tr_TR |
dc.identifier.issn | 1300-0152 | - |
dc.identifier.uri | https://doi.org/10.3906/biy-1703-104 | - |
dc.identifier.uri | https://journals.tubitak.gov.tr/biology/vol41/iss6/7/ | - |
dc.identifier.uri | 1303-6092 | - |
dc.identifier.uri | http://hdl.handle.net/11452/30375 | - |
dc.description.abstract | The MTT assay is one of the often used cell viability/cytotoxicity assays. However, when the methanol extracts of plants are used to test their cytotoxic potential, interference may occur, resulting in false-positive viability results. Therefore, in this study, the reliability of the MTT assay was investigated in the case of plant use. The methanol extracts of three different plants (Hypericum adenotrichum, Salvia kronenburgii, and Pelargonium quercetorum) were tested in breast cancer cell lines (MCF-7 and MDA-MB-231) using the MTT assay and the results were compared to the ATP assay, which is a much more sensitive and reliable assay due to its interference-free feature. Additionally, decreased cell density was confirmed with phase-contrast microscopy and fluorescence staining (Hoechst 33342 dye). Although both of the viability/cytotoxicity assays are considered as metabolic assays, viabilities (in %) in the MTT assay were found to be strikingly higher when compared to the results with the ATP assay. Even in the case of total death, the MTT assay still produced artificial/false increases in viability. The morphology-based evaluation of viability/cytotoxicity by phase-contrast microscopy and Hoechst 33342 staining were greatly compatible with the ATP assay results. Overestimated (false) viabilities in the MTT assay suggests a serious interference between the MTT assay itself and the extracts used. Some ingredients of plants may have reducing activity (like the dehydrogenase activity of the cells) that converts the MTT compound into the colored formazan that is the principle of the assay. Therefore, the MTT assay may not be a suitable assay for some plant extracts, urging great caution when plants are used | en_US |
dc.language.iso | en | en_US |
dc.publisher | TÜBİTAK | tr_TR |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.rights | Atıf Gayri Ticari Türetilemez 4.0 Uluslararası | tr_TR |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | Life sciences & biomedicine - other topics | en_US |
dc.subject | ATP assay | en_US |
dc.subject | Breast cancer | en_US |
dc.subject | Cytotoxicity | en_US |
dc.subject | Interference | en_US |
dc.subject | MTT assay | en_US |
dc.subject | Plant extract | en_US |
dc.subject | Rapid colorimetric assay | en_US |
dc.subject | Tetrazolium salt | en_US |
dc.subject | Cyto-toxicity | en_US |
dc.subject | In-vitro | en_US |
dc.subject | Reduction | en_US |
dc.subject | Growth | en_US |
dc.subject | Atp | en_US |
dc.subject | Proliferation | en_US |
dc.subject | Lines | en_US |
dc.subject | Survival | en_US |
dc.title | The MTT viability assay yields strikingly false-positive viabilities although the cells are killed by some plant extracts | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000418253100007 | tr_TR |
dc.identifier.scopus | 2-s2.0-85038415566 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Fen-Edebiyat Fakültesi/Biyoloji Bölümü. | tr_TR |
dc.relation.bap | BUAP(F)-2014/3 | en_US |
dc.contributor.orcid | 0000-0002-6729-7908 | tr_TR |
dc.identifier.startpage | 919 | tr_TR |
dc.identifier.endpage | 925 | tr_TR |
dc.identifier.volume | 41 | tr_TR |
dc.identifier.issue | 6 | tr_TR |
dc.relation.journal | Turkish Journal of Biology | en_US |
dc.contributor.buuauthor | Arı, Ferda | - |
dc.contributor.researcherid | AAG-7012-2021 | tr_TR |
dc.relation.collaboration | Yurt içi | tr_TR |
dc.indexed.trdizin | TrDizin | tr_TR |
dc.identifier.pubmed | 30814856 | tr_TR |
dc.subject.wos | Biology | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | PubMed | en_US |
dc.wos.quartile | Q4 | en_US |
dc.contributor.scopusid | 24376085300 | tr_TR |
dc.subject.scopus | Ovary Carcinoma; Drug Response; Irinotecan | en_US |
Appears in Collections: | Scopus TrDizin Web of Science |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Arı_vd_2017.pdf | 1.76 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License